News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Nico Gagelmann: Closing the Gap – PTCy Boosts Survival After Mismatched Stem Cell Transplants
Nico Gagelmann
Jun 18, 2025, 15:13

Nico Gagelmann: Closing the Gap – PTCy Boosts Survival After Mismatched Stem Cell Transplants

Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared a post on X:

“Out now in Journal of Clinical Oncology.
Closing the Gap: PTCy Boosts Survival After Mismatched Stem Cell Transplants
Summary:
In a multicenter phase II trial, post-transplant cyclophosphamide (PTCy)-based GVHD prophylaxis enabled strong 1-year survival outcomes in patients receiving peripheral blood stem cell transplants from HLA-mismatched unrelated donors (MMUDs).
Among 145 patients – 59% from underrepresented groups – 1-year overall survival reached 83.8% (MAC) and 78.6% (RIC/NMA), with low rates of severe GVHD.
Outcomes were comparable regardless of the degree of mismatch. These findings suggest PTCy regimens can safely expand donor access across all ethnic backgrounds.”

Nico Gagelmann

More posts featuring Nico Gagelmann on OncoDaily.

Abeer Madbouly Alison Loren Antonio Martin Jimenez Jimenez ASCO Brent Logan Brian C. Shaffer Bronwen E. Shaw cancer Craig Malmberg Dipenkumar Modi EHA Erin Leckrone European Hematology Association Farhad Khimani Heather E. Stefanski Janelle Olson Jeffery J. Auletta Jianqun Kou Journal of Clinical Oncology Juan Wu Karen Ballen Karilyn Larkin Larisa Broglie Mahasweta Gooptu Martin Maiers Medhat Askar Mehdi Hamadani Monzr M. Al Malki Muna Qayed Nico Gagelmann OncoDaily Oncology post-transplant cyclophosphamide PTCy Rachel Cook Rachel Cusatis Sally Arai Sarah Smith Stem Cell Transplants Stephanie Bo-Subait Stephanie Fingerson Stephen R. Spellman Steven Michael Devine Sung Won Choi The EBMT
Special Coverage
Blog
Jun 18, 2025, 16:23
David Sebag-Montefiore: Join the 3rd International Multidisciplinary Anal Cancer Conference at the University of Leeds
Blog
Jun 18, 2025, 15:55
How Associate Professor Simon Chu is Rewriting the Story For a Rare Form of Ovarian Cancer - OCRF
Insight
Jun 18, 2025, 15:34
Amol Akhade: Top Sessions to Watch at ESMO GI 2025 – Clinical Innovation Meets Pragmatism
Insight
Jun 18, 2025, 15:32
Filippo Alongi Shared Study on Real-World Safety and Feasibility of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients
Insight
Jun 18, 2025, 15:30
ESTRO Highlighted 5-Year ABLATIVE Trial Results on MRI-Guided Single-Dose Breast Irradiation
Blog
Jun 18, 2025, 15:21
Carmen Monge-Montero Highlights Cancer Survivorship and Advocacy at Latest Episode of MANO Podcast
Blog
Jun 18, 2025, 15:15
Elen Baloyan: It Was A Pleasure To Be Invited to the Youth Cancer Europe’s Equity, Diversity and Inclusion Forum
Insight
Jun 18, 2025, 15:13
Nico Gagelmann: Closing the Gap - PTCy Boosts Survival After Mismatched Stem Cell Transplants
Blog
Jun 18, 2025, 15:10
Gerard Walls: Absolutely Epic ESTRO Breur Award Lecture From Professor Corinne Faivre-Finn Last Week
Opinion
Jun 18, 2025, 15:08
Razelle Kurzrock: Once Again, DART Hits A Target
Blog
Jun 18, 2025, 14:16
Mazvita Sengayi-Muchengeti: It Was Great to be Part of the Team Working on IARC Monograph 139
Blog
Jun 18, 2025, 14:08
MD Anderson Cancer Center Shared Fumiko Chino's Story: From Caregiver to a Radiation Oncologist